https://www.selleckchem.com/pr....oducts/epz015666.htm
nd no significant difference between the right vs left upper extremity approach. To evaluate the 3-year safety and effectiveness of the MDT-2113 (IN.PACT Admiral) drug-coated balloon (DC vs percutaneous transluminal angioplasty (PTA) in a Japanese population with femoropopliteal occlusive disease. The multicenter, prospective, IN.PACT SFA Japan randomized controlled trial ( identifier NCT01947478) was an independently adjudicated study evaluating Japanese participants randomized 21 to DCB (n=68) or PTA (n=32). The effectiveness endp
Like
Comment
Share
